Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice

Molecular Immunology

Volumn 94, Issue , 2018, Pages 54-60

  Dekkers, Gillian ^a   Bentlage, Arthur E H ^a   Plomp, Rosina ^b   Visser, Remco ^a   Koeleman, Carolien A M ^b   Beentjes, Anna ^a   Mok, Juk Yee ^c   van Esch, Wim J E ^c   Wuhrer, Manfred ^b   Rispens, Theo ^a   Vidarsson, Gestur ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sanquin Reagents   (Netherlands)

Author keywords

Fc gamma receptors; Fucosylation; Human; Immunoglobulin; Murine; N Glycosylation

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIIA; FC RECEPTOR IIIB; FC RECEPTOR IV; FUCOSE; GALACTOSE; GLYCAN; IMMUNOGLOBULIN G; PROTEIN VARIANT; UNCLASSIFIED DRUG; IMMUNOGLOBULIN FC FRAGMENT; POLYSACCHARIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOTINYLATION; FUCOSYLATION; GLYCOSYLATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; CARBOHYDRATE ANALYSIS; CELL CULTURE; CHEMISTRY; CONSERVED SEQUENCE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; CARBOHYDRATE SEQUENCE; CELLS, CULTURED; CONSERVED SEQUENCE; FUCOSE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MICE; POLYSACCHARIDES; RECEPTORS, IGG; SPECIES SPECIFICITY;

EID: 85038234853     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2017.12.006     Document Type: Article

References (46)

1. Ackerman, M.E., Crispin, M., Yu, X., Baruah, K., Boesch, A.W., Harvey, D.J., Dugast, A.-S., Heizen, E.L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P.A., Bailey-Kellogg, C., Scanlan, C., Alter, G., Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123 (2013), 2183–2192, 10.1172/JCI65708.
2. Bruggeman, C.W., Dekkers, G., Bentlage, A.E.H., Treffers, L.W., Nagelkerke, S.Q., Lissenberg-Thunnissen, S., Koeleman, C.A.M., Wuhrer, M., van den Berg, T.K., Rispens, T., Vidarsson, G., Kuijpers, T.W., Enhanced effector functions due to antibody defucosylation depend on the effector cell Fcγ receptor profile. J. Immunol. 199 (2017), 204–211, 10.4049/jimmunol.1700116.
3. Bruhns, P., Jönsson, F., Mouse and human FcR effector functions. Immunol. Rev. 268 (2015), 25–51, 10.1111/imr.12350.
4. Chambers, M.C., Maclean, B., Burke, R., Amodei, D., Ruderman, D.L., Neumann, S., Gatto, L., Fischer, B., Pratt, B., Egertson, J., Hoff, K., Kessner, D., Tasman, N., Shulman, N., Frewen, B., Baker, T.a., Brusniak, M.-Y., Paulse, C., Creasy, D., Flashner, L., Kani, K., Moulding, C., Seymour, S.L., Nuwaysir, L.M., Lefebvre, B., Kuhlmann, F., Roark, J., Rainer, P., Detlev, S., Hemenway, T., Huhmer, A., Langridge, J., Connolly, B., Chadick, T., Holly, K., Eckels, J., Deutsch, E.W., Moritz, R.L., Katz, J.E., Agus, D.B., MacCoss, M., Tabb, D.L., Mallick, P., A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30 (2012), 918–920, 10.1038/nbt.2377.
5. Dashivets, T., Thomann, M., Rueger, P., Knaupp, A., Buchner, J., Schlothauer, T., Multi-angle effector function analysis of human monoclonal IgG glycovariants. PLoS One, 10, 2015, e0143520, 10.1371/journal.pone.0143520.
6. de Haan, N., Reiding, K.R., Krištić, J., Hipgrave Ederveen, A.L., Lauc, G., Wuhrer, M., The N-glycosylation of mouse immunoglobulin G (IgG)-fragment crystallizable differs between IgG subclasses and strains. Front. Immunol. 8 (2017), 1538–1547, 10.3389/fimmu.2017.00608.
7. de Lau, W., Barker, N., Low, T.Y., Koo, B.-K., Li, V.S.W., Teunissen, H., Kujala, P., Haegebarth, A., Peters, P.J., van de Wetering, M., Stange, D.E., van Es, J.E., Guardavaccaro, D., Schasfoort, R.B.M., Mohri, Y., Nishimori, K., Mohammed, S., Heck, A.J.R., Clevers, H., Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476 (2011), 293–297, 10.1038/nature10337.
8. Dekkers, G., Plomp, R., Koeleman, C.A.M., Visser, R., von Horsten, H.H., Sandig, V., Rispens, T., Wuhrer, M., Vidarsson, G., Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans. Sci. Rep., 6, 2016, 36964, 10.1038/srep36964.
9. Dekkers, G., Bentlage, A.E.H., Stegmann, T.C., Howie, H.L., Lissenberg-Thunnissen, S., Zimring, J., Rispens, T., Vidarsson, G., Affinity of human IgG subclasses to mouse Fc gamma receptors. MAbs 9 (2017), 767–773, 10.1080/19420862.2017.1323159.
10. Dekkers, G., Treffers, L., Plomp, R., Bentlage, A.E.H., de Boer, M., Koeleman, C.A.M., Lissenberg-Thunnissen, S.N., Visser, R., Brouwer, M., Mok, J.Y., Matlung, H., van den Berg, T.K., van Esch, W.J.E., Kuijpers, T.W., Wouters, D., Rispens, T., Wuhrer, M., Vidarsson, G., Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front. Immunol., 8, 2017, 877, 10.3389/fimmu.2017.00877.
11. Edberg, J.C., Kimberly, R.P., Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. J. Immunol. 159 (1997), 3849–3857.
12. Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., Umaña, P., The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 281 (2006), 5032–5036, 10.1074/jbc.M510171200.
13. Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A.C., Stihle, M., Umaña, P., Benz, J., Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 12669–12674, 10.1073/pnas.1108455108.
14. Hayes, J.M., Frostell, A., Karlsson, R., Müller, S., Millan-Martin, S., Pauers, M., Reuss, F., Cosgrave, E., Anneren, C., Davey, G.P., Rudd, P.M., Identification of Fc gamma receptor glycoforms that produce differential binding kinetics for rituximab. Mol. Cell. Proteom., 2017, 10.1074/mcp.M117.066944 mcp.M117.066944.
15. Houde, D., Peng, Y., Berkowitz, S.a., Engen, J.R., Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol. Cell. Proteom. 9 (2010), 1716–1728, 10.1074/mcp.M900540-MCP200.
16. Howie, H.L., Delaney, M., Wang, X., Er, L.S., Vidarsson, G., Stegmann, T.C., Kapp, L., Lebedev, J.N., Wu, Y., AuBuchon, J.P., Zimring, J.C., Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti-immunoglobulin reagent. Transfusion 56 (2016), 2953–2962, 10.1111/trf.13812.
17. Huizinga, T.W., Kleijer, M., Tetteroo, P.A., Roos, D., von dem Borne, A.E., Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood 75 (1990), 213–217.
18. Jefferis, R., Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol. Sci. 30 (2009), 356–362, 10.1016/j.tips.2009.04.007.
19. Kaneko, Y., Nimmerjahn, F., Ravetch, J.V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (2006), 670–673, 10.1126/science.1129594.
20. Kapur, R., Della Valle, L., Sonneveld, M., Hipgrave Ederveen, A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166 (2014), 936–945, 10.1111/bjh.12965.
21. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C.A.M., Visser, R., Einarsdottir, H.K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A.M., Blank, D., Skogen, B., Killie, M.K., Michaelsen, T.E., de Haas, M., Rispens, T., van der Schoot, C.E., Wuhrer, M., Vidarsson, G., A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123 (2014), 471–480, 10.1182/blood-2013-09-527978.
22. Kapur, R., Della Valle, L., Verhagen, O.J.H.M., Hipgrave Ederveen, A., Ligthart, P., de Haas, M., Kumpel, B., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion 55 (2015), 553–562, 10.1111/trf.12880.
23. Maresch, D., Altmann, F., Isotype-specific glycosylation analysis of mouse IgG by LC-MS. Proteomics 16 (2016), 1321–1330, 10.1002/pmic.201500367.
24. Mimura, Y., Kelly, R.M., Unwin, L., Albrecht, S., Jefferis, R., Goodall, M., Mizukami, Y., Mimura-Kimura, Y., Matsumoto, T., Ueoka, H., Rudd, P.M., Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. J. Immunol. Methods 428 (2016), 30–36, 10.1016/j.jim.2015.11.009.
25. Nimmerjahn, F., Ravetch, J.V., Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310 (2005), 1510–1512, 10.1126/science.1118948.
26. Nimmerjahn, F., Bruhns, P., Horiuchi, K., Ravetch, J.V., FcyRIV: a novel FcR with distinct IgG subclass specificity. Immunity 23 (2005), 41–51, 10.1016/j.immuni.2005.05.010.
27. Nimmerjahn, F., Anthony, R.M., Ravetch, J.V., Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 8433–8437, 10.1073/pnas.0702936104.
28. Plomp, R., Dekkers, G., Rombouts, Y., Visser, R., Koeleman, C.A.M., Kammeijer, G.S.M., Jansen, B.C., Rispens, T., Hensbergen, P.J., Vidarsson, G., Wuhrer, M., Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3). Mol. Cell. Proteom. 14 (2015), 1373–1384, 10.1074/mcp.M114.047381.
29. Rodenko, B., Toebes, M., Hadrup, S.R., van Esch, W.J.E., Molenaar, A.M., Schumacher, T.N.M., Ovaa, H., Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat. Protoc. 1 (2006), 1120–1132, 10.1038/nprot.2006.121.
30. Schasfoort, R.B.M., Andree, K.C., van der Velde, N., van der Kooi, A., Stojanović, I., Terstappen, L.W.M.M., Interpolation method for accurate affinity ranking of arrayed ligand-analyte interactions. Anal. Biochem. 500 (2016), 21–23, 10.1016/j.ab.2016.01.023.
31. Shibata-Koyama, M., Iida, S., Okazaki, A., Mori, K., Kitajima-Miyama, K., Saitou, S., Kakita, S., Kanda, Y., Shitara, K., Kato, K., Satoh, M., The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation. Glycobiology 19 (2009), 126–134, 10.1093/glycob/cwn110.
32. Shields, R.L., Namenuk, A.K., Hong, K., Meng, Y.G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., Fox, J.a., Presta, L.G., High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J. Biol. Chem. 276 (2001), 6591–6604, 10.1074/jbc.M009483200.
33. Shields, R.L., Lai, J., Keck, R., O'Connell, L.Y., Hong, K., Meng, Y.G., Weikert, S.H.a., Presta, L.G., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277 (2002), 26733–26740, 10.1074/jbc.M202069200.
34. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., Hanai, N., Shitara, K., The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278 (2003), 3466–3473, 10.1074/jbc.M210665200.
35. Sondermann, P., Huber, R., Oosthuizen, V., Jacob, U., The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406 (2000), 267–273, 10.1038/35018508.
36. Sonneveld, M.E., Natunen, S., Sainio, S., Koeleman, C.A.M., Holst, S., Dekkers, G., Koelewijn, J., Partanen, J., van der Schoot, C.E., Wuhrer, M., Vidarsson, G., Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br. J. Haematol. 174 (2016), 310–320, 10.1111/bjh.14053.
37. Sonneveld, M.E., Koelewijn, J., de Haas, M., Admiraal, J., Plomp, R., Koeleman, C.A.M., Hipgrave Ederveen, A.L., Ligthart, P., Wuhrer, M., van der Schoot, C.E., Vidarsson, G., Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. Br. J. Haematol. 176 (2017), 651–660, 10.1111/bjh.14438.
38. Subedi, G.P., Barb, A.W., The structural role of antibody N-glycosylation in receptor interactions. Structure 23 (2015), 1573–1583, 10.1016/j.str.2015.06.015.
39. Subedi, G.P., Barb, A.W., The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor. MAbs 8 (2016), 1512–1524, 10.1080/19420862.2016.1218586.
40. Tao, M.H., Morrison, S.L., Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143 (1989), 2595–2601.
41. Thomann, M., Schlothauer, T., Dashivets, T., Malik, S., Avenal, C., Bulau, P., Rüger, P., Reusch, D., In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity. PLoS One, 10, 2015, e0134949, 10.1371/journal.pone.0134949.
42. Vink, T., Oudshoorn-Dickmann, M., Roza, M., Reitsma, J.J., de Jong, R.N., A simple, robust and highly efficient transient expression system for producing antibodies. Methods 65 (2014), 5–10, 10.1016/j.ymeth.2013.07.018.
43. Wang, T.T., Sewatanon, J., Memoli, M.J., Wrammert, J., Bournazos, S., Bhaumik, S.K., Pinsky, B.A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., Taubenberger, J.K., Ahmed, R., Ravetch, J.V., IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity. Science 355 (2017), 395–398, 10.1126/science.aai8128.
44. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C.A.M., Deelder, A., de Haas, M., Vidarsson, G., Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J. Proteome Res. 8 (2009), 450–456, 10.1021/pr800651j.
45. Yasuma, R., Cicatiello, V., Mizutani, T., Tudisco, L., Kim, Y., Tarallo, V., Bogdanovich, S., Hirano, Y., Kerur, N., Li, S., Yasuma, T., Fowler, B.J., Wright, C.B., Apicella, I., Greco, A., Brunetti, A., Ambati, B.K., Helmers, S.B., Lundberg, I.E., Viklicky, O., Leusen, J.H., Verbeek, J.S., Gelfand, B.D., Bastos-Carvalho, A., De Falco, S., Ambati, J., Intravenous immune globulin suppresses angiogenesis in mice and humans. Signal Transduct. Target. Ther., 1, 2016, 15002, 10.1038/sigtrans.2015.2.
46. Zeck, A., Pohlentz, G., Schlothauer, T., Peter-Katalinić, J., Regula, J.T., Cell type-specific and site directed N-glycosylation pattern of Fc RIIIa. J. Proteome Res. 10 (2011), 3031–3039, 10.1021/pr1012653.